These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14598660)

  • 1. [Systemic lupus erythematosus with steroid induced non-alcoholic steatohepatitis: a case report].
    Kamata Y; Kamimura T; Yoshio T; Hirata D; Masuyama J; Isoda N; Kanai N; Minota S
    Ryumachi; 2003 Oct; 43(4):667-71. PubMed ID: 14598660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case of NASH exacerbated after testectomy due to seminoma].
    Morizono S; Nakamuta M; Ohta S; Fukushima M; Kotoh K; Enjoji M; Nawata H
    Fukuoka Igaku Zasshi; 2004 Jun; 95(6):146-51. PubMed ID: 15387271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of systemic lupus erythematosus associated with fatty liver and Basedow's disease].
    Itateyama E; Dohmen K; Nishizaka H; Shibuya T; Nakamura H; Arase K; Yokogawa Y; Asayama R; Ishibashi H
    Fukuoka Igaku Zasshi; 1994 Mar; 85(3):101-7. PubMed ID: 8175101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fatty hepatosis. Non-alcoholic steatohepatitis (evolution of the knowledge about clinico-morphological features, prognosis, treatment)].
    Podymova SD
    Ter Arkh; 2006; 78(4):32-8. PubMed ID: 16821419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up CT findings of tamoxifen-induced non-alcoholic steatohepatitis (NASH) of breast cancer patients treated with bezafibrate.
    Ogawa Y; Murata Y; Saibara T; Nishioka A; Kariya S; Yoshida S
    Oncol Rep; 2003; 10(5):1473-8. PubMed ID: 12883726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
    Yoshioka Y; Hashimoto E; Yatsuji S; Kaneda H; Taniai M; Tokushige K; Shiratori K
    J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fat diet and alcohol-induced steatohepatitis after LPS challenge in mice: role of bioactive TNF and Th1 type cytokines.
    Olleros ML; Martin ML; Vesin D; Fotio AL; Santiago-Raber ML; Rubbia-Brandt L; Spahr L; Hadengue A; Garcia I
    Cytokine; 2008 Oct; 44(1):118-25. PubMed ID: 18722787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic steatohepatitis.
    Das K; Kar P
    J Assoc Physicians India; 2005 Mar; 53():195-9. PubMed ID: 15926603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of non-alcoholic steatohepatitis (NASH) with chronic neutrophilic leukemia.
    Yoshida C; Kojima H; Iijima T; Katsura Y; Shimizu S; Suzukawa K; Mukai HY; Hasegawa Y; Abei M; Nagasawa T
    Eur J Haematol; 2004 Mar; 72(3):225-8. PubMed ID: 14962243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic steatohepatitis--a histological perspective.
    Sakhuja P; Malhotra V
    Indian J Pathol Microbiol; 2006 Apr; 49(2):163-72. PubMed ID: 16933708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
    Federico A; Trappoliere M; Loguercio C
    Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
    Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and therapy in NASH].
    Tokushige K
    Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nonalcoholic steatohepatitis (NASH): therapeutic approaches].
    Buscher HP
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S60-2. PubMed ID: 15368170
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus.
    Orikasa H; Ohyama R; Tsuka N; Eyden BP; Yamazaki K
    J Submicrosc Cytol Pathol; 2001; 33(1-2):195-200. PubMed ID: 11686402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis.
    Sreenivasa Baba C; Alexander G; Kalyani B; Pandey R; Rastogi S; Pandey A; Choudhuri G
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):191-8. PubMed ID: 16706832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.